ArticleOncotarget2017

miR-146a promotes growth of osteosarcoma cells by targeting ZNRF3/GSK-3β/β-catenin signaling pathway.

Chun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.